Basic Information
OCTAGAM SOLUTION FOR INFUSION 50 mg/ml
INJECTION
Regulatory Information
SIN10859P
April 6, 1999
Prescription Only
Therapeutic
INTRAVENOUS
August 10, 2023
June 3, 2025
XJ06BA02
Company Information
WELLCHEM PHARMACEUTICALS PTE LTD
WELLCHEM PHARMACEUTICALS PTE LTD
Active Ingredients
Strength: 50 mg/ml
Detailed Information
Contraindications
**4.3 Contraindications** Hypersensitivity to any of the components of Octagam. Hypersensitivity to homologous immunoglobulins, especially in the very rare cases of IgA deficiency when the patient has antibodies against IgA.
Indication Information
**4.1 Therapeutic Indications** _4.1.1 Replacement therapy in:_ - Primary immunodeficiency syndromes such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia - common variable immunodeficiency - severe combined immunodeficiency - Wiskott Aldrich syndrome - Myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections - Children with congenital AIDS and recurrent infections. _4.1.2 Immunomodulation:_ - Idiopathic thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count. - Guillain Barré syndrome - Kawasaki disease _4.1.3 Allogeneic bone marrow transplantation_